| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Gorman Kevin Charles is a Director at NEUROCRINE BIOSCIENCES INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 22 sells.
Estimated insider holdings value: $82.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 5,314 | $138.74 | $737,270.71 | -0.5% | +3.4% | -8.8% | |
| Jan 31, 2024 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 2,707 | $140.69 | $380,844.58 | -0.5% | -1.6% | +9.7% | |
| Jan 9, 2024 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sale+OE | 167,858 | $133.02 | $22,328,417.31 | -14.4% | +4.3% | +3.7% | |
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 9,328 | $107.40 | $1,001,816.01 | -1.8% | +1.0% | +38.1% | |
| Feb 8, 2023 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 29,044 | $102.90 | $2,988,757.87 | -1.5% | -6.9% | +28.6% | |
| Jan 31, 2023 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 2,707 | $110.08 | $297,997.12 | -0.6% | -6.2% | +26.0% | |
| Feb 8, 2022 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 10,984 | $80.54 | $884,674.32 | -0.6% | -5.2% | +30.7% | |
| Feb 8, 2021 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 12,888 | $116.26 | $1,498,368.03 | -0.7% | - | - | |
| Jan 8, 2021 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sale+OE | 308,250 | $110.22 | $33,973,876.51 | -25.9% | - | - | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 3,390 | $90.78 | $307,747.59 | -0.8% | - | - |